Newstral
Article
wsj.com on 2021-01-12 18:15
China’s Sinovac Covid-19 Vaccine Is 50.4% Effective in Late-Stage Brazil Trials
Related news
- BSinovac: Brazil results show Chinese vaccine 50.4% effectivebbc.co.uk
- Brazil data shows China vaccine 50.4% effectiveBBC
- HTurkey says China’s Sinovac COVID Vaccine 91.25% Effective in Late Trialshamodia.com
- Coronavirus: Brazil reports more modest 50.4 per cent efficacy for China’s Sinovac vaccineSouth China Morning Post
- BBrazil Approves Import of China’s Sinovac Vaccinebloomberg.com
- Brazil Suspends Trials of China’s Sinovac Coronavirus Vaccinewsj.com
- Brazil suspends trials of China's Sinovac coronavirus vaccine, citing 'serious adverse event'CNN
- Coronavirus: a Sinovac Biotech vaccine is seen as effective in BrazilSouth China Morning Post
- China’s COVID vaccine CoronaVac just 50 percent effective, new trials findNew York Post
- In clinical and real world trials, China’s Sinovac underperformsThe Economist
- Sinovac coronavirus vaccine 78% effective in Brazil trial: instituteSydney Morning Herald
- Brazil suspends clinical trials for China’s coronavirus vaccineisraelnationalnews.com
- New Brazil data shows disappointing 50.4% efficacy for China's CoronaVac vaccineSydney Morning Herald
- Coronavirus: Brazil study finds Sinovac far less effective at reducing deaths in elderlySouth China Morning Post
- China’s Sinovac says Covid-19 vaccine has high efficacy after lower Brazil figureSouth China Morning Post
- Coronavirus: Brazil approves emergency use of vaccines from AstraZeneca and China’s SinovacSouth China Morning Post
- Chile says China’s Sinovac coronavirus vaccine 67 per cent effective against symptomatic infectionSouth China Morning Post
- Brazil data shakes confidence in China's Sinovac coronavirus vaccineCNN International
- China’s Sinovac COVID-19 vaccine induces quick antibody responses: studyherald.co.zw